Merck: Game-Changing Oncology Drugs Power Stock Surge (NYSE:MRK)

This article was written by Follow With over two decades of dedicated experience in investment, Allka…

Merck: Undervalued Pharma Stock With Defensive Approach And Compelling Dividend Yield

This article was written by Follow Dear Reader,I am a Senior Derivatives Expert with over 10…

Undercovered Dozen: Applied Digital, Merck, B2Gold And More

This article was written by Follow Some tickers are covered more than others on the site,…

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) – Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from…

Why Merck Is A Better Dividend Stock Than Gilead Sciences (NYSE:MRK)

This article was written by Follow Envision Research, aka Lucas Ma, has over 20+ years of…

Merck & Co., Inc. (MRK) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Merck & Co., Inc. (NYSE:MRK) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 10:00…

Merck & Co., Inc. (MRK) BofA Securities 2025 Healthcare Conference (Transcript)

Merck & Co., Inc. (NYSE:MRK) BofA Securities 2025 Healthcare Conference May 14, 2025 1:40 PM ET…